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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanBackground: The clinical impact of Chryseobacterium indologenes infection is increasing;
nevertheless, most studies had been conducted in northern Taiwan, but rarely in central
Taiwan.
Methods: Using 16S rRNA gene sequencing, 34 isolates of C. indologenes were identified at the
Central Region Hospital Alliance between 2007 and 2011. Vitek 2 and matrix-assisted laser
desorption ionizationetime-of-flight mass spectrometry (MALDIeTOF MS) methods were
compared for the feasibility to identify this bacterium. Drug susceptibility test, biofilm forma-
tion, and pulsed-field gel electrophoresis (PFGE) were also performed.
Results: All isolates were collected from hospitalized patients with an average age of
70.8  18.5years. The most prevalent sample was urine (50.0%), followed by sputum
(32.4%). The accuracy rate of species-level identification reached 94.1% using the Vitek 2
method and 85.3% using the MALDIeTOF MS method. All of the isolates were resistant to genta-
micin, amikacin, ceftriaxone, chloramphenicol, colistin, and imipenem, but completely
susceptible to minocycline. While analyzing biofilm-forming ability, 38.2% (13/34) of C. indo-
logenes isolates displayed a positive phenotype using the LuriaeBertani (LB) medium. Howev-
er, 80.0% (4/5) of invasive isolates were biofilm producers. Based on PFGE analysis, several
clusters were found, and the possible intrahospital spread of this bacterium in this area could
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560 Y.-C. Chang et al.Conclusion: Both Vitek 2 and MALDIeTOF MS methods showed good ability in the determination
of C. indologenes. Among the examined drugs, minocycline was the most potent one. As many
as 38.2% C. indologenes isolates showed biofilm-forming ability. PFGE analyses revealed the
possible intrahospital transmission of this bacterium in central Taiwan.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Chryseobacterium indologenes, previously classified under
the Flavobacterium CDC group IIb,1 is a rare human path-
ogen that is widely distributed in soil, plants, and water.
The clinical importance of C. indologenes has increased in
recent years after being identified as the causative agent
of bacteriemia,2 pneumonia,3 indwelling device-
associated infection,4 peritonitis,5 and ocular infection.6
Bacteremia and pneumonia caused by this bacterium
generally result in high mortality, which may partly be
attributed to the inherent multidrug-resistant trait of C.
indologenes.7
In clinical microbiology laboratories, conventional
methods are generally used for the identification of glucose
nonfermenting Gram-negative bacilli, including C. indolo-
genes. However, the main drawback of conventional
methods that detect the active metabolic processes in the
bacteria is that these are time consuming. Some commer-
cial kits, such as a Vitek 2 GN card, have been developed for
saving of both time and labor.8 When necessary, 16S rRNA
gene sequencing, a molecular method, is recommended as
the standard method for the identification of bacteria.9
Nevertheless, complexity and high cost of the technique
hamper its routine application. In recent years, matrix-
assisted laser desorption ionizationetime-of-flight mass
spectrometry (MALDIeTOF MS) has widely been applied in
the identification of many bacterial species, including
glucose nonfermenting Gram-negative bacilli.10,11 Howev-
er, literature concerning the feasibility of this technique in
the identification of C. indologenes is limited.
In addition, little was known about the virulence de-
terminants of Chryseobacterium species.12 Biofilm is a mi-
crobial community that attaches to a solid surface that is
surrounded by extracellular polymeric substances produced
by the microorganism(s).13 The bacterial biofilm formed in
the human body may lead to septicemia or more serious
consequences.13 Biofilm formation has been reported to be
associated with infections caused by C. indologenes and a
related species, Elizabethkingia meningoseptica.14,15
However, to the best of our knowledge, no survey of the
biofilm-forming ability of clinical C. indologenes isolates
has been reported.
The first aim of this study was to compare Vitek 2 and
MALDIeTOF MS methods for the identification of C. indo-
logenes using 16S rRNA gene sequencing as the standard
method. The potential biofilm-forming ability of this bac-
terium was then explored. In addition, antibiogram and
pulsed-field gel electrophoresis (PFGE) pattern were
investigated to provide more information regarding C.
indologenes infection in central Taiwan.Methods
Patients and bacterial isolates
C. indologenes isolates were collected by the Central
Laboratory of the Central Region Hospital Alliance,
including mainly Taichung Hospital, Fongyuan Hospital,
Changhwa Hospital, and Nantou Hospital, from 2007 to
2011. All the patients’ medical records were retrospec-
tively studied.
16S rDNA identification
Genomic DNA extraction was performed using the genomic
DNA purification kit (Biokit, Miaoli, Taiwan). A primer pair
(50-AGAGTTTGATCMTGGCTCAG-30 and 50-GGY-
TACCTTGTTACGACTT-30) was used.16 The subsequent poly-
merase chain reaction and DNA sequencing were performed
as previously reported,17 and then the DNA sequence data
were BLASTed using the NCBI database.
MALDIeTOF MS
MALDIeTOF MS was performed using the Microflex LT sys-
tem and analyzed by the Bruker Biotyper 3.0 software
(Bruker Daltonics, Bremen, Germany). In brief, a score of
<1.700 was interpreted as no identification, 1.700e1.999
indicated an identification to the genus level, 2.000e2.299
indicated a reliable identification of the genus and a
probable species identification, and 2.300e3.000 repre-
sented a high probability of species identification.
Biochemical discrimination and antimicrobial
susceptibility
Vitek 2 GN and AST cards (bioMe´rieux, Marcy-l’Etoile,
France) were used for biochemical identification and drug
susceptibility assay, respectively, according to the manu-
facturer’s instruction. The minimum inhibitory concentra-
tions (MICs) were interpreted according to the Clinical and
Laboratory Standards Institute criteria for other non-
Enterobacteriaceae.18
Biofilm analysis
The bacteria were inoculated on the brain heart infusion
agar plates at 37C for 18e20 hours, washed twice, and
resuspended in different broths [LB, tryptic soy broth (TSB),
or M9 minimal medium (M9)] to the turbidity of McFarland
0.5, and then diluted 100-fold with respective medium.
Table 1 Demographic and clinical features of 34 patients
with Chryseobacterium indologenes infection
Variables No. (%)
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transferred to a 96-well polyvinyl chloride microtiter plate
and incubated at 37C for 15 hours. Each well was washed
thrice with sterile phosphate-buffered saline (pH 7.5) and
stained with a 0.25% crystal violet solution. Triple reactions
were performed for each isolate. Any isolate with absorp-
tion greater than twofold of the blank at OD570 was regar-
ded as positive for biofilm formation.19Sputum 11 (32.4)
Blood 4 (11.8)








Diabetes mellitus 15 (44.1)
Old stroke 9 (26.5)
Chronic renal failure 9 (26.5)
Hypertensive heart disease 7 (20.6)
Chronic obstructive pulmonary disease 5 (14.7)
Chronic respiratory failure 5 (14.7)PFGE analysis
Plugs were prepared as previously described,17 and the
genomic DNA was digested with XhoI. The genomic DNA of
Salmonella enterica serovar Braenderup H9812, digested
with XbaI, was used as the molecular weight marker.20
PFGE was performed using the CHEF-DR III system (Bio-
Rad; Hercules, CA, USA). The gel was run at a field strength
of 6.0 V/cm, at a reorientation angle of 120, and from an
initial switch time of 0.5 seconds to a final switch time of
26.4 seconds. The result was analyzed by GelComparII
software (Applied Maths NV, St-Martens-Latem, Belgium).
Dice similarity coefficients were calculated using un-
weighted pair group mean association.Cervical spondylosis, liver cirrhosis,
phthisis, gastric cancer, lymphoma
1 (2.9, each)Results
Characteristics of patients
The average age of the 34 patients was 70.8  18.5 years,
and only five (14.7%) patients were younger than 50 years.
All were hospitalized patients and approximately half were
female. Twenty-five patients had underlying diseases,
including diabetes mellitus (n Z 15, 44.1%), chronic renal
failure (n Z 9, 26.5%), and old stroke (n Z 9, 26.5%; Table
1). The major sample was urine (50.0%), followed by
sputum (32.4%).Comparison of identification methods
Using 16S rRNA gene sequencing as the gold standard, 34
isolates were identified as C. indologenes, with sequence
similarity ranging from 99.0% to 100% (data not shown).
The identification results of the 34 isolates by the Vitek 2
and MALDIeTOF MS methods were compared (Table 2). By
the Vitek 2 method, 32 isolates were identified as C.
indologenes with acceptable discrimination (94.1%),
whereas one isolate was identified as C. indologenes with
unacceptable discrimination (2.9%) and one was regarded
as Chryseobacterium gleum with acceptable discrimina-
tion (2.9%). Using MALDIeTOF MS, 29 isolates were
correctly identified to the species level (85.3%), four to
the genus level (11.8%), and one could not be identified
(2.9%). MALDIeTOF MS failed to identify four isolates that
were recognized using a Vitek 2 GN card (isolates 17, 24,
29, and 33; data not shown), but successfully distinguished
one isolate that could not be classified by the Vitek 2
method (isolate 23; data not shown). However, one isolate
could not be identified properly by both these methods
(isolate 32).Drug susceptibility
The 34 C. indologenes isolates were highly resistant to most
drugs examined (Table 3). All the isolates were completely
resistant to gentamicin, amikacin, ceftriaxone, chloram-
phenicol, colistin, and imipenem. Susceptibilities of the C.
indologenes isolates to trimethoprim/sulfamethoxazole
and ciprofloxacin were 52.9% (18/34) and 14.7% (5/34),
respectively. The most potent drug examined was minocy-
cline, to which isolates showed 100% susceptibility.
Biofilm formation
Of the C. indologenes isolates, 38.2% (13/34), 17.6% (6/34),
and 0% (0/34) displayed biofilm-forming ability using the
LB, TSB, and M9 media, respectively (Table 4). The biofilm-
forming rate of C. indologenes isolates from sputum and
urine was 45.5% (5/11) and 23.5% (4/17), respectively. As
many as 80.0% (4/5) invasive isolates (4 from blood and 1
from cerebrospinal fluid) were biofilm producers.
PFGE analysis
Epidemiological relatedness of the 34 isolates from central
Taiwan was determined by PFGE (Fig. 1). With a similarity
coefficient of 75% as a cutoff value, four major clusters
were found with seven, six, five, and four members,
respectively, whereas the remaining 10 isolates were
genetically diverse. In addition, two isolates (isolates 10
and 18) showed a smear of unresolvable DNA fragments
after PFGE analyses (data not shown). Further examination
of the hospital sources of these members among the four
Table 2 Comparison of Vitek 2 with Bruker Biotyper for Chryseobacterium indologenes identification
Bruker Vitek 2
Identification Scorea C. indologenes Chryseobacterium gleum
Acceptableb Unacceptable Acceptable
C. indologenes 2.300 24 1
2.000e2.299 4
Chryseobacterium sp. 1.700e1.999 3 1
No identification <1.700 1
a <1.700: no identification; 1.700e1.999: genus-level identification; 2.000e2.299: secure genus identification and probable species
identification; 2.300e3.000: highly probable species identification.
b 85% probability.
Table 3 Drug susceptibility pattern of 34 isolates
Antimicrobial agent MIC50 (mg/mL) MIC90 (mg/mL) Susceptibility breakpoint (mg/mL) Susceptible (%)
Gentamicin 16 16 4 0
Amikacin 64 64 16 0
Ceftazidime 64 64 8 2.9
Ceftriaxone 64 64 8 0
Cefepime 64 64 8 2.9
Chloramphenicol 64 64 8 0
Ciprofloxacin 4 4 1 14.7
Colistin 16 16 2 0
Imipenem 16 16 4 0
Piperacillin 128 128 16 2.9
Piperacillin/tazobactam 128/4 128/4 16/4 2.9
Minocycline 1 1 4 100
TMPeSMZ 2/38 16/304 2/38 52.9
MIC Z minimum inhibitory concentration; TMPeSMZ Z trimethoprim/sulfamethoxazole.
562 Y.-C. Chang et al.major clusters demonstrated that each cluster contained
multiple isolates from the same hospital (Fig. 1).
Discussion
Patients were all hospitalized and mostly older people with
underlying disease(s) (73.5%). An equivalent or even higher
prevalence of patients with various kinds of underlying
diseases was observed in previous reports.7,21 The two
major samples in this study were urine and sputum. How-
ever, the most dominant sample previously reported is
sputum.7Table 4 Comparison of different media for the biofilm
formation of C. indologenes isolates from different samples
Source Biofilm formation (%)
TSB LB M9
Urine (n Z 17) 3 (17.6) 4 (23.5) 0 (0.0)
Sputum (n Z 11) 2 (18.1) 5 (45.5) 0 (0.0)
Blood (n Z 4) 1 (25.0) 3 (75.0) 0 (0.0)
Cerebrospinal fluid (n Z 1) 0 (0.0) 1 (100.0) 0 (0.0)
Eye discharge (n Z 1) 0 (0.0) 0 (0.0) 0 (0.0)
Total (n Z 34) 6 (17.6) 13 (38.2) 0 (0.0)
LB Z LuriaeBertani; TSB Z tryptic soy broth.In this study, the correct rates for species-level identi-
fication by the Vitek 2 and MALDIeTOF MS methods were
94.1% and 85.3%, respectively. Even though these two
methods had previously been employed for the identifica-
tion of C. indologenes,8,10,11 to the best of our knowledge,
this was the first trial to compare these two methods
focusing on this bacterium. Nevertheless, owing to the
limited number of isolates used in this study, we tended not
to conclude the priority of these two methods. Interest-
ingly, isolate 32 was misidentified as C. gleum using Vitek 2
with a probability of 99.0% and recognized as Chrys-
eobacterium species by MALDIeTOF MS method with a score
of 1.771 (data not shown). It might imply the atypical na-
ture of this isolate and emphasize the necessity of 16s rRNA
gene sequencing as a standard method.
The multidrug-resistant trait of C. indologenes isolates
from central Taiwan was as serious, if not more, as the
isolates previously reported in other areas of Taiwan.7,22
For example, studies conducted in northern7 and south-
ern22 Taiwan revealed 87.4% and 100% susceptibilities to
trimethoprim and sulfamethoxazole, respectively. Howev-
er, only 52.9% susceptibility was observed in this study.
Undoubtedly, minocycline, to which isolates showed 100%
susceptibility in this survey and 92e100% in previous re-
ports,2,22 emerged as the most active drug against C.
indologenes infection.
A higher rate of biofilm formation was found in sputum
isolates than in urine isolates, which might reflect the
Figure 1. PFGE dendrogram of 34 C. indologenes isolates. The presenting cluster was grouped with a similarity coefficient of
75% as a cutoff value. C Z Changhua Hospital; F Z Fongyuan Hospital; N Z Nantou Hospital; T Z Taichung Hospital.
C. indologenes isolates in central Taiwan 563variation in colonization potential of C. indologenes at
different sites. The observation of invasive isolates with a
higher rate of biofilm formation led to the speculation of a
pathogenetic role of biofilm in this bacterium. However,
the small number (N Z 5) of invasive isolates limited us
from making a conclusion. LB showed the highest potential
for biofilm formation (38.2%), whereas the M9 medium
could not support this bacterium to form a biofilm. It is
noteworthy that richer nutrient contents of a medium
favor biofilm formation in Hafnia alvei.23 However, our
results revealed that the biofilm-forming ability of C.
indologenes in the richer medium (TSB) was lower than
that in the LB medium (Table 4). It was previously
observed that E. meningoseptica isolates displayed a 100%
biofilm-forming ability in the LB medium, and mortality
was associated with an increased biofilm formation by this
bacterium.14 In an earlier study, C. indologenes causing
multiple episodes of bacteremia by the same strain was
thought to be related to biofilm formation.4 Based on the
diversity of the biofilm-forming potential between these
two bacterial species, it was proposed that C. indologenes
may be less virulent than E. meningoseptica. In addition,
the minimum biofilm eradication concentration of imipe-
nem toward Pseudomonas aeruginosa ATCC 27853 is 1000-
fold higher than the minimum inhibitory concentration.24
It is possible that the formation of biofilm by C.indologenes may also reduce its susceptibility to antimi-
crobial agents.
PFGE patterns revealed four major clusters with a
similarity coefficient of 75% as a cutoff value. Each
cluster contained multiple isolates from the same hospital
(Fig. 1). Similarity cutoff values of 75e85% are generally
applied for PFGE grouping of bacteria.25,26 However, even
with a cutoff value of 80% or 85%, we could observe
related isolates (e.g., isolates 13, 14, and 16) that were
from the same source (Fig. 1). In addition, these three
isolates shared an identical susceptibility pattern (sus-
ceptible to minocycline, but resistant to all other drugs
examined; data not shown). Thus, the possibility of an
intrahospital spread of certain clone(s) in this area could
not be excluded. Using random amplification of poly-
morphic DNA analysis, isolates recovered from different
patients at a medical center in northern Taiwan within an
8-month period were proved to be clonally unrelated.4
More recent research in northern Taiwan also demon-
strated, using PFGE profiles, no cluster among C. indolo-
genes bacteremic isolates.7 Isolates from patients with
cystic fibrosis in Italy were also found to be genetically
independent.27 Therefore, the finding of possible intra-
hospital transmission of C. indologenes in central Taiwan
highlights the necessity of continuous monitoring in the
future.
564 Y.-C. Chang et al.In this study, MALDIeTOF MS and Vitek 2 methods
showed comparable ability in identifying C. indologenes.
The 34 examined isolates were multidrug resistant, and
38.2% had biofilm-forming ability. It was noteworthy that
both drug resistance and biofilm formation might increase
the difficulty in treatment. In addition, epidemiological
relatedness among some of the 34 isolates alerted the
possibility of intrahospital spread in central Taiwan. Given
the increasing clinical importance of C. indologenes,
continuous surveillance of this bacterium in this area is
recommended.Conflicts of interest
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